ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Mochida Pharmaceutical Co., Ltd. ?
1
Company has very low debt and has enough cash to service the debt requirements
2
Poor long term growth as Net Sales has grown by an annual rate of 0.65% and Operating profit at -1.59% over the last 5 years
3
The company declared negative results in Mar'25 after flat results in Dec'24
- INTEREST(9M) At JPY 2 MM has Grown at 100%
- INVENTORY TURNOVER RATIO(HY) Lowest at 1.6%
4
With ROE of 4.35%, it has a very attractive valuation with a 0.85 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -3.68%, its profits have risen by 17.7% ; the PEG ratio of the company is 1.1
- At the current price, the company has a high dividend yield of 0
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -3.68% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Mochida Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Mochida Pharmaceutical Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Mochida Pharmaceutical Co., Ltd.
-3.68%
0.40
23.09%
Japan Nikkei 225
28.54%
1.11
25.75%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.65%
EBIT Growth (5y)
-1.59%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.80
Tax Ratio
29.40%
Dividend Payout Ratio
49.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.13%
ROE (avg)
5.66%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
0.85
EV to EBIT
7.33
EV to EBITDA
5.38
EV to Capital Employed
0.75
EV to Sales
0.57
PEG Ratio
1.10
Dividend Yield
0.02%
ROCE (Latest)
10.22%
ROE (Latest)
4.35%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
ROCE(HY)
Highest at 4.66%
RAW MATERIAL COST(Y)
Fallen by -0.36% (YoY
-6What is not working for the Company
INTEREST(9M)
At JPY 2 MM has Grown at 100%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.6%
Here's what is working for Mochida Pharmaceutical Co., Ltd.
Raw Material Cost
Fallen by -0.36% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Mochida Pharmaceutical Co., Ltd.
Interest
At JPY 2 MM has Grown at 100%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Inventory Turnover Ratio
Lowest at 1.6% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
